Asia Pacific Drug Delivery Systems Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Drug Delivery Systems Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Drug Delivery Systems Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Drug Delivery Systems Market Regional Analysis

6.2 Asia Pacific Drug Delivery Systems Market Revenue 2016-2027 (US$ Million)

6.3 Asia Pacific Drug Delivery Systems Market Forecast Analysis

7. Asia Pacific Drug Delivery Systems Market Analysis – by Route of Administration

7.1 Transmucosal

7.1.1 Overview
7.1.2 Transmucosal: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.2 Oral

7.2.1 Overview
7.2.2 Oral: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.3 Injectable

7.3.1 Overview
7.3.2 Injectable: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.4 Topical

7.4.1 Overview
7.4.2 Topical: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.5 Implantable

7.5.1 Overview
7.5.2 Implantable: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.6 Ocular

7.6.1 Overview
7.6.2 Ocular: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Asia Pacific Drug Delivery Systems Market Analysis – by Distribution Channel

8.1 Hospital Pharmacies

8.1.1 Overview
8.1.2 Hospital Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Retail Pharmacies

8.2.1 Overview
8.2.2 Retail Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.3 Online Pharmacies

8.3.1 Overview
8.3.2 Online Pharmacies: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Asia Pacific Drug Delivery Systems Market Analysis – by Application

9.1 Home Care Settings

9.1.1 Overview
9.1.2 Home Care Settings: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.2 Hospitals & Clinics

9.2.1 Overview
9.2.2 Hospitals & Clinics: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. Asia Pacific Drug Delivery Systems Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Drug Delivery Systems Market Breakdown, by Key Country, 2019 and 2027 (%)
10.2.1.1 Asia Pacific Drug Delivery Systems Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 China: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
10.2.1.1.2 China: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
10.2.1.1.3 China: Asia Pacific Drug Delivery Systems Market Breakdown, by Application

10.2.1.2 India: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 India: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
10.2.1.2.2 India: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
10.2.1.2.3 India: Asia Pacific Drug Delivery Systems Market Breakdown, by Application

10.2.1.3 Japan: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
10.2.1.3.2 Japan: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
10.2.1.3.3 Japan: Asia Pacific Drug Delivery Systems Market Breakdown, by Application

10.2.1.4 Australia: Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
10.2.1.4.2 Australia: Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
10.2.1.4.3 Australia: Asia Pacific Drug Delivery Systems Market Breakdown, by Application

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market Breakdown, by Route of Administration
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market Breakdown, by Distribution Channel
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Drug Delivery Systems Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 BD

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 3M

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Novo Nordisk A/S

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BD

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novo Nordisk A/S

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Boston Scientific Corporation

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Bausch Health Companies Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Baxter

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Boehringer Ingelheim

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Novartis AG

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 GlaxoSmithKline plc.

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 Johnson & Johnson Services, Inc.

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Drug Delivery Systems Market

Analysis and Forecasts by Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country